DVM, MS, DACVIM
Dr. Craig Clifford has been board certified in medical oncology by the American College of Veterinary Internal Medicine since 2003. He joined Hope Veterinary Specialists in 2012 as a medical oncologist and Director of Clinical Studies and has played an integral role in establishing the oncology department. He oversees the clinical studies program, which enables Hope Veterinary Specialists to offer cutting-edge technologies and novel therapies to oncology patients and patients of other specialties. These studies will benefit both patients and their owners.
Dr. Clifford graduated from Mississippi State University College of Veterinary Medicine in 1999. He completed an internship and a medical oncology residency at the University of Pennsylvania in 2003 and joined Red Bank Veterinary Hospital as a medical oncologist and Director of Clinical Research in 2002. In 1993, he received an MS in Animal Science/Virology from the University of Delaware. He received his undergraduate degree from Muhlenberg College in Allentown, Pennsylvania, in 1990.
Dr. Clifford and his family live in Montgomery County with their son and 2 dogs (Franklin and Willowbee). He enjoys sports of all kinds and traveling.
Dr. Clifford is a well-renowned oncologist who has authored/co-authored over 60 papers and book chapters. He was responsible for the creation of the Veterinary Cancer Society‘s resident review session and the Northeast Veterinary Co-operative Oncology Group. He is a frequent lecturer at major veterinary meetings in the United States and abroad and participates in Hope Veterinary Specialists-sponsored symposiums. Dr. Clifford has served on the VCS executive board, ACVIM Exam Rating Committee, Residency Training and Credentials Committee, ACVIM IOCART committee, ACVIM Strategic Planning Committee, and Oncology Pathology Working Group. He has been a co-chair of the Standards of Excellence in Residency Education Task Force and an examiner for the Australian Scientist’s Oncology Specialty Exam. He is a consultant for the Veterinary Information Network and also serves on the Scientific Advisory Boards for Industry (VRS Health, Q-Biotics, NovaVive, Zoetis, Elanco, Merial/Boehringer Ingelheim, Jaguar Animal Health, Plumbline Life Sciences, and Aratana) as well as several foundations including the Animal Cancer Foundation, Day by Day, and Puppy Up.
Saba CF, Clifford CA, Burgess KE, et al. Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials. Veterinary and Comparative Oncology 2020 C
J.M. Fenger, W.C. Eward, W.P.D. Hendricks, E.A. McNiel, C. Johannes, S.B. Richard, L.S. Treml, D. Bruyette, A.J. Mutsaers, J.P. Woods, C.A. Clifford, et al. Delivering Innovation to Oncology Drug Development through Cancer Drug DISCO: Perspectives, Gaps and Solutions. Annals of Medical and Clinical Oncology. 2020. C
Thamm, DH, Avery AC, Bulman-Flemic J, Berlato D, Clifford CA, et al. Prognostic Significance and predictive significance of KIT protein expression and c-kit mutation in canine cutaneous mast cell tumours: A consensus of the Oncology-Pathology-Working Group. VCO 2019;17:451-455.
Kirsch, M, Weisse, C, Berent, A, Clifford CA, et al. Pilot study comparing serum chemotherapy levels after intra-arterial and intravenous administration in dogs with naturally occurring urinary tract tumors. J of Can Vet Res. 2019;83187-196.
Saba, CF, Vickery KR, Clifford CA, et al. Rabacfosadine for relapsed canine B‐cell lymphoma: Efficacy and adverse event profiles of 2 different doses. 2018;16:E76-82.
Weishaar KM, Ehrhart EJ, Avery AC, Charles JB, Elmslie RE, Vail DM, London CA, Clifford CA, et al. c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine. JVIM DOI: 10.1111/jvim. 14889.
Mullin C, Clifford CA. Canine insulinoma. Clinician’s Brief. 2017;15(9):85-89.
Kicenuik, K, Northrup N, Dawson A, Locke J, Villamil JA, Chretin J, Sfiligoi S, Clifford CA, et al. Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal®, or no closed system transfer device for administration of cancer chemotherapy to a dog model. VCO 2017;15:163–173
Mullin CM, Clifford CA. Which Drugs Are Used for Medical Management of Lymphoma in Dogs & Cats? Clinicians Brief (Part 1,2,3) Nov, Dec 2016, Jan 2017
BA Marker, LG Barber, CA Clifford, et al. Extravasation reaction associated with the administration of pamidronate: 11 cases (2008-2013). VCO 2016 DOI:10.1111/vco.12191
Paek M, Glass E, Kent M, Clifford CA, De Lahunta A. Primary Lumbar Extradural Hemangiosarcoma in a Dog. JAAHA 2015; 51, No. 3, pp. 191-196
Clifford CA, Mullin C. Consultant on Call, Oncology: Feline Lymphoma. NAVC Clinician’s Brief 2015;13(7):72
Gouldin ED, Mullin C, Morges M, Mehler SJ, de Lorimier LP, Oakley C, Risbon RE, May L, Kahn SA and Clifford CA. Feline discrete high-grade gastrointestinal lymphoma treated with surgical resection and adjuvant CHOP-based chemotherapy: retrospective study of 20 cases. Vet Comp Oncol, 2015 DOI: 10.1111/vco.12166
Gardner HL, London CA, Portela RA, Nguyen S, Rosenberg MR, Klein MK, Clifford CA, et al. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma. BMC Veterinary
Research 2015;11:131 DOI: 10.1186/s12917-015-0446-1
Burton, JH, Venable RO, Vail DM, Williams LE, Clifford CA, et al. Pulse-Administered Toceranib plus Lomustine for the Treatment of Unresectable Canine Mast Cell Tumors. JVIM 2015;29:1098–1104
London C, Gardner H, Mathie T, Stingle N, Portela R, Pennell M, CA Clifford, et al. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma Following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study. Plos One 2015
Culp WTN, Weisse C, Berent A, Reetz JA, Krick EL, Jackson DE, Kass PH, CA Clifford et al. Comparison of Intra-Arterial and Intravenous Carboplatin for Early Tumor Response in Naturally-Occurring Canine Lower Urinary Tract Carcinoma. JVIM 2015;29: 900–907
CM Mullin, MA Arkans, CD Sammarco, DM Vail, BM Britton, KR Vickery, RE Risbon, J Lachowicz, KE Burgess, C Manley, and CA Clifford. Doxorubicin chemotherapy for presumptive cardiac hemangiosarcoma in dogs. Vet Comp
Oncol, 2014 DOI: 10.1111/vco.12131
KA Kraus CA Clifford, GJ Davis, et al. Outcome and prognostic indicators in cats undergoing splenectomy for splenic mast cell tumor. JAAHA. 2015;51: 231-238
Burr DH, Keating JH, CA Clifford, et al. Cutaneous lymphoma of the tarsus in cats: 23 cases (2000–2012). JAVMA 2014; 244:1429-1434
RK Sivacolundhu, TA Donovan, LG Barber, CF Saba, CA Clifford, et al. Ulnar osteosarcoma in dogs: 30 cases (1992-2008). JAVMA 2013;24:96-101
SA Kahn, CM Mullin, de Lorimier LP, Burgess KE, Risbon RE, Fred RM, Drobatz K and CA Clifford. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: A pilot study. Canadian Veterinary Journal 2013;237-242.
M Linderman, G Post, E Brodsky, LP deLroimier and CA Clifford. Feline Exocrine Pancreatic Carcinoma: 34 cases. Veterinary and Comparative Oncology 2013;11:208-18
D.M. Vail, H. von Euler, A.W. Rusk, L. Barber, CA. Clifford, et al. A Randomized Trial Investigating the Efficacy and Safety of Water Soluble Micellar Paclitaxel (Paccal Vet) for Treatment of Nonresectable Grade 2 or 3 Mast Cell Tumors in Dogs. JVIM 2012;26:598-607
C London, T Mathie, N Stingle, CA Clifford, et al. Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours. Veterinary and Comparative Oncology Vet Comp Oncol. 2012;10:194-205.
G Dank, KM Rassnick, O Kristal, CO Rodriguez, CA Clifford, et al. Clinical characteristics, treatment, and outcome of dogs with presumed primary hepatic lymphoma: 18 cases (1992–2008). JAVMA 2011;239:966-971
J Wiley, J Rook, CA Clifford, G Thomas, KU Sorenmo. Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous hemangiosarcoma. Vet Comp Oncology 2010;8:221-233.
KA Skorupski CO Rodriguez, EL Krick, CA Clifford, R Ward, MS Kent Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy. Vet Comp Oncol. 2009;7:139-44.
S Haney, L Beaver, J Turrel, CA Clifford, et al. A survival analysis for nasal lymphoma in 97 cats: a multi-institutional retrospective study. JVIM 2009;23:287-94.
EJ Bulakowski, JC Philibert, S Siegel, CA Clifford, R Risbon, et al. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006). JAVMA 2008;233:122-8.
KL Mealey, J Fidel, J Gay, J Impellizeri, CA Clifford, Phil Bergman. ABCB1-1 Polymorphism Can Predict Hematologic Toxicity in Dogs Treated with Vincristine. JVIM 2008;22:996-1000.
E L Krick, L Little, R Patel, F S Shofer, K Sorenmo, C A Clifford, J L Baez Description of clinical and pathological findings, treatment and outcome of feline large granular lymphocyte lymphoma (1996-2004).Vet Comp Oncol.
N J Mason, C M Coughlin, B Overley , J N Cohen , E L Mitchell, T A Colligon , C A Clifford, A Zurbriggen, K U Sorenmo, R H Vonderheide. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma. Gene Ther. 2008;15:955-65.
K Sorenmo, M Samluk, CA Clifford, et al. Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma. JVIM. 2007;21:1347-54.
RE Risbon, CA Clifford, and K Skorupski. An overview of canine histiocytic disorders. Vet Med 2007; 102: 464-480.
T Britt, CA Clifford, A Barger, et al. Diagnosing appendicular osteosarcoma with ultrasound-guided fine-needle aspiration: 36 cases. J Small Anim Pract. 2007;48:145-50.
KA Skorupski, CA Clifford, MC Paoloni, et al. CCNU for the treatment of dogs with histiocytic sarcoma. JVIM 2007;21:121-6.
CJ McNeill, B Overley, FS Shofer, MS Kent, CA Clifford, et al. Characterization of the Biological Behaviour of Appendicular Osteosarcoma in Rottweilers and a Comparison with Other Breeds: A Review of 258 Dogs
Vet Comp Oncol. 2007;5:90-98.
Risbon RE, Clifford CA, Burgess KE, et al.. Response of Canine Cutaneous Epitheliotropic Lymphoma to Lomustine (CCNU): A retrospective study of 46 cases (1999-2004). JVIM 2006;20:1389–1397.
Weisse C, Berent A, Todd K, Clifford CA, Solomon J. Palliative Stenting for Malignant Urethral Obstructions in 12 Dogs. JAVMA 2006;229:226-34.
Heller DA, Clifford CA, Goldschmidt MH, Holt DE, Manfredi MJ, Sorenmo KU. Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor. Vet Pathol 2005;42:350-3.
Heller DA, Clifford CA, Goldschmidt MH, et al. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.Vet Pathol. 2005;42:776-80.
Sorenmo KU, Baez JL, Clifford CA, Mauldin E, Overley B, Skorupski K, Bachman R, Samluk M, and Shofer F. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma. JVIM 2004;18:209-13.
Clifford CA, Pretorius ES, Weisse C, Siegelman ES; Sorenmo KU, and Solomon JR. Magnetic Resonance Imaging of Canine Splenic and Hepatic Lesions: A Pilot Study. JVIM 2004;18:330-338.
Radhakrishnan A, Risbon RE, Patel RT, and Clifford CA. Progression of an extramedullary plasmacytoma to multiple myeloma in a cat. Veterinary Clinical and Comparative Oncology 2004;2:36-43.
Weisse C, Clifford CA, Nicholson M, Holt D, Hurst R, Solomon JA. Percutaneous Bland Arterial Embolization and Chemoembolization for the Treatment of Benign and Malignant Diseases. Journal of the American Veterinary Medical Association. JAVMA 2002;221;1430-1436.
Herndon WE, Kittleson MD, Sanderson K, Drobatz KJ, Clifford CA, Gelzer A, Summerfield NJ, Linde A, and Sleeper MM. Cardiac Troponin I in Feline Hypertrophic Cardiomyopathy. Journal of Veterinary Internal Medicine 2002;16:558-564.
Clifford CA, Hughes D, Beal MW, Henry CJ, Drobatz KJ, and Sorenmo KU. Vascular endothelial growth factor concentrations in body cavity effusions in dogs. Journal of Veterinary Internal Medicine 2002;16:164-168.
Sleeper MM, Clifford CA, Laster LL. Cardiac troponin I in the normal dog and cat. Journal of Veterinary Internal Medicine 2001;15:501-503.
Clifford CA, Hughes D, Beal MW, Mackin AJ, Henry CJ, Shofer FS, and Sorenmo KU. Plasma vascular endothelial growth factor (VEGF) concentrations in healthy dogs and dogs with hemangiosarcoma. Journal of Veterinary Internal Medicine 2001;15:131-135.
Clifford CA, Mackin AJ, Henry CJ, Treatment of canine hemangiosarcoma: 2000 and beyond. Journal of Veterinary Internal Medicine 2000;14:479-484.
Clifford CA, Sorenmo K. Doxorubicin cardiotoxicity: current concepts on pathogenesis, cardioprotection and screening. Veterinary Cancer Society Newsletter; Spring 2000.
Clifford CA, Weigand C, Jennings D, Maslin WR. What’s your neurologic diagnosis? Journal of the American Veterinary Medical Association 2000;216:1217-1219.
Henry CJ, Turnquist SE, Smith A, Graham JC, Thamm DH, Obrien M, Clifford CA. Primary renal tumors in cats: 19 cases (1992-1998). European Journal of Feline Medicine and Surgery 1999;1:165-170.
Clifford CA: The characterization of the Mississippi -B (Miss-B) reovirus isolate: pathogenesis, persistence and effect on the immune system. Masters Thesis, University of Delaware 1993.
Bergman PJ, Clifford CA. Recent Advancements in Oncology: Editors Veterinary Clinics of North America (VCNA). 2019.
Mullin C, Clifford CA: Updates in Canine Hemangiosarcoma and Histiocytic sarcoma; VCNA 2019.
Clifford CA, Skorupski KA, Moore PF. The Histiocytic Diseases. In Withrow and Mac Ewen’s Small Animal Clinical Oncology, 6th Edition. 2019.
Mullin C, Clifford CA. Hmangiosarocma. In Withrow and Mac Ewen’s Small Animal Clinical Oncology, 6th Edition. 2019.
Mullin C, Clifford CA: Histiocytic sarcoma and Hemangiosarcoma Updates: Cancer in Companion Animal Veterinary Clinics of North America: 2019
Clifford CA. Plumb's Veterinary Drugs; Chapters include: Vincristine, Vinblastine, Cytarabine, Fluorouracil, Hydroxyurea. 2018.
Slenksy K and Clifford CA. Chapter 73. Sick oncology patients in the emergency room. Textbook of Small Animal Emergency Medicine, Drobtaz (Ed). Wiley. 2018.
Clifford CA, Mullin C, Banks T. Multimodal approaches to surgical oncology. In Veterinary Surgical Oncology, 2nd edition. Iowa: Wiley-Blackwell. In Press.
Clifford CA, LP de Lorimier. Hemangiosarcoma: Textbook of Veterinary Internal Medicine Expert Consult, 8th Ed Ettinger and Feldman ed. 2016
LP de Lorimier, Clifford CA. Chemotherapy related toxicities: Textbook of Veterinary Internal Medicine Expert Consult, 8th Ed Ettinger and Feldman ed. 2016
Mullin C, Clifford CA, Oncology for the Interventionalist. In Weisse’s Veterinary Image-Guided Interventions. 2015.
Clifford CA, Mullin CM. Bile Duct Carcinoma. In Blackwell’s Five-Minute Veterinary Consult: Canine and Feline, Sixth Edition. Iowa: Wiley-Blackwell. 2014.
Clifford CA, Mullin CM. Hemangiosarcoma, Bone. In Blackwell’s Five-Minute Veterinary Consult: Canine and Feline, Sixth Edition. Iowa: Wiley-Blackwell. 2014
Clifford CA, Mullin CM. Hemangiosarcoma, Heart. In Blackwell’s Five-Minute Veterinary Consult: Canine and Feline, Sixth Edition. Iowa: Wiley-Blackwell. 2014
Clifford CA, Mullin CM. Hemangiosarcoma, Spleen and Liver. In Blackwell’s Five-Minute Veterinary Consult: Canine and Feline, Sixth Edition. Iowa: Wiley-Blackwell. 2014
Clifford CA, Mullin CM. Hemangiosarcoma, Skin. In Blackwell’s Five-Minute Veterinary Consult: Canine and Feline, Sixth Edition. Iowa: Wiley-Blackwell. 2014.
Clifford CA, Skorupski KA, Moore PF. The Histiocytic Diseases. In Withrow and Mac Ewen’s Small Animal Clinical Oncology, 5th Edition. 2012.
Fan TM, Clifford CA, LP de Lorimier, Garrett LD, Neoplastic and Non-Neoplastic tumors. In Muller and Kirk’s; Small Animal Dermatology 7th Ed. 2012.
Clifford CA, DeLorimer LP. Canine Hemangiosarcoma: Current Concepts. Current Vet Therapy XIV 2013.
Clifford CA, Fischetti A, Goggins J, Pretorius ES. Use of Computed Tomography and Magnetic Resonance Imaging in Veterinary Oncology. Handbook of Oncology. 1st edition 2009
Clifford CA, DeLorimer LP. Canine Hemangiosarcoma: Current Concepts. Current Vet Therapy XIV 2008.
Clifford CA, Skorupski KA. The Histiocytic Diseases. Handbook of Oncology 1st edition 2009
Clifford CA, Skorupski KA: The Histiocytic Diseases. In Withrow and Mac Ewen’s Small Animal Clinical Oncology, 4th Edition. 2006.
Clifford CA, Sorenmo KU. Tumors of the Larynx and Trachea; a chapter in the Textbook of Respiratory Disease in Dogs and Cats, Lesley G. King, ed. Philadelphia, PA: W.B. Saunders. 2004.
Lectures Provided: Palliative Care in the Veterinary and Internal Medicine Patient, Anorexia and Vomiting in the Oncology Patient, VMX 2020 Jan Orlando, Fla
Lectures Provided: Mast cell tumors; Recent advancements in Oncology, Hemangiosarcoma, Updates in Lymphoma, California VMA, Yosemite National park 2020
Lectures Provided: Mast cell tumors; Updates in Lymphoma. COMOV, Madrid, Spain 2019
Lectures Provided: How to read a histopath report; Controversies in Oncology, Mast cell, Metronomic Therapy, Immunotherapy; Tumors of the abdomen and Thorax. National Veterinary Conference, Moscow, Russia. 2019
Lectures Provided: Recent Advancements in Oncology, Updates in Canine and feline Lymphoma. Palliative Care and the Oncology Patient, Soft tissue sarcomas: Are they a dime a dozen? Controversies in Oncology: Mast cell tumors. Pacific Vet Conference, San Diego Ca 2019
Lectures Provided: Recent Advancements in Oncology, Transitional Cell Carcinoma, What’s New and What You Need to Know, Palliative Care and the Oncology Patient, The Importance of Immunophenotyping in Canine Lymphoma. NAVC, Orlando, Fla. 2019
Lectures Provided: Cat are not small dogs; When an oncologist and surgeon team up. Khedi ISFM, Istanbul, Turkey 2018
Lectures Provided: The Clinical and Economic Utility of TANOVEA-CA1 for Canine Lymphoma; Panel Discussion: What Clinical Oncologists Would Like to See When New Treatments or Diagnostics Are Commercialized ACVIM 2018, Seattle, Wa.
Lecture provided on: Clinical trials in private practice.Veterinary Surgical Society of Oncology, Maui, Hawaii, 2018.
Lectures provided on: Tanovea, Soft tissue sarcoma, Controversies in Mast cell tumors, Updates on canine and feline lymphoma, Recent advancements in Oncology, Palliative care and the oncologist. VetVacations: Aruba, 2018.
Lectures provided on: Controversies in Oncology: Metronomic therapy, Lymphoma, Immunotherapy; Multimodal approach to the tumors of the abdomen and thorax. Dutch Oncology Congress, Amsterdam, Netherlands 2017
Lectures provided on: Chemotherapy and the surgeon, How to read a histopathology repeat; Clinical staging and the surgeon. AVCS Ann Conf Seattle, Wa. 2016
Lecture provided on: Clinical Application of Immunotherapeutics in Veterinary Oncology. NAVC, Orlando Fl. 2016
Lecture provided on: Clinical Application of Immunotherapeutics in Veterinary Oncology. WVC, Las Vegas, NV. 2016
Lectures provided on: Controversies in Oncology; Lymphoma, Melanoma, Metronomic therapy and Mast cell tumors. ACVIM Annual Conference, Indianapolis, IN. 2015
Lectures provided on: Recent advancements in oncology; Updates in Canine and Feline Lymphoma; Canine Hanmgiosarcoma and Mast cell tumors. Virginia VMA, Roanoke Va. 2015
Lectures provided on: Recent advancements in oncology; Cased Based Lymphoma; Novel Therapies, Palliative Care and the Oncology Patient, Common skin tumors, Melanoma: Current Concepts, Feline thoracic tumors;
Feline intra-abdominal tumors; Injection site sarcoma; 4th National Congress in Veterinary Medicine, Lisbon, Portugal 2014.
Lectures provided on Mast cell tumors, Updates in Canine Lymphoma, Novel Therapies, Oral tumors and Soft tissue sarcoma. ACVC Annual Meeting, Atlantic City NJ, 2014
Lectures provided on: Case based approach to oncology; oral tumors, intrathoracic tumors, intra-abdominal tumor and perianal tumors. ACVIM Annual Conference, Nashville Ky 2014
Lectures provided: Recent advancements in Oncology; Oral tumors; Canine Lymphoma, Tysosine Kinase Inhibitors; Keystone Annual PVMA meeting, April 2014, Penn St, PA
Lectures provided on: Recent advancement in feline oncology; Tyrosine kinase inhibitors; Feline thoracic tumors; Feline intra-abdominal tumors; Injection site sarcoma; Feline squamous cell carcinoma; Feline mast cell tumors. Dutch Oncology Congress, Utrecht, Netherlands 2013
Lectures provided on: Recent advancements in oncology; Current concepts in Lymphoma. Australian and New Zealand College of Veterinary Scientists Science Week, Surfers Paradise 2013
Lectures provided on: Recent advancements in oncology; Current concepts in lymphoma; Canine osteosarcoma; How to read histopathology reports; Tyrosine kinase receptor inhibitors: ACVC, Annual Conference Atlantic City, NJ 2012
Lectures provided on: Canine and Feline Lymphoma, What’s new in Oncology, How to read a histopathology report; Canine mast cell tumours and TKIs; Canine Hemangiosarcoma. Melbourne Veterinary Specialists Centre 1st Annual
Continuing Education Event; Melbourne, Australia 2011.
Lectures provided on: Recent advancements in oncology; Current concepts in Lymphoma; Canine Hemangiosarcoma; Cytology and Histopathology, an oncologist’s view; mammary gland tumors in the dog; Vaccine-associated sarcomas: Current Concepts; 1st National Congress in Veterinary Medicine, Lisbon, Portugal 2010.
Biologic Activity of Toceranib Phosphate (Palladia™) in Canine Apocrine Gland Anal Sac Adenocarcinoma (AGASACA). 30th Annual Conference, Veterinary Cancer Society, 2010
Academia vs Private Practice vs Industry – The Possibilities are Endless! ACVIM Annual Conference Anaheim, Ca 2010
Oncologic Emergencies. ACVIM Annual Conference San Antonio 2008
Evaluation of a 10 week CHOP + CCNU protocol for relapse canine lymphoma: 72 cases. 27th Annual Conference, Veterinary Cancer Society, Ft Lauderdale, FL 2007
Canine Hemangiosarcoma: Current Concepts; Canine Lymphoma: Long vs Short Protocols: ACVC, Annual Conference Atlantic City, NJ 2007
Canine Hemangiosarcoma: Current Concepts: ACVIM Annual Conference Seattle WA 2007.
Evaluation of a Doxorubicin and Deracoxib Protocol for the Treatment of Splenic Hemangiosarcoma (HSA): A Pilot Study. 25th Annual Conference, Veterinary Cancer Society, 2005
Lymphoma: Short vs. Long Protocol; Point Counterpoint: (Clifford CA, Burgess KE). ACVIM Annual Conference 2005
Lectures provided on: Chemotherapy: Principles and Practice; Canine Hemangiosarcoma; Controversies in Oncology; NSAIDs and Cancer. Penn Conference 2005
Novartis Lecture Series: NSAIDs and Cancer; Vermont 2005, Cabo San Lucas, Mexico 2005; North American Veterinary Conference, Orlando Fl, 2005; St Augustine 2005; Veterinary Orthopedic Society Annual Conference 2004. American Animal Hospital Association Annual Conference 2003
Lectures provided on: Canine Hemangiosarcoma, NSAIDs and Cancer, Lymphoma, past and present; Chemotherapy: Principles and Practice PVMA Annual Conference 2004; Happy Valley, PA; 2004
Magnetic Resonance Imaging of Canine Splenic Lesions. 24th Annual Conference. Veterinary Cancer Society, Kansas City, MO 2004
MR Imaging of Canine Splenic and Hepatic Lesions: A Pilot Study. 22nd Annual Conference. Veterinary Cancer Society, New York, NY 2002.
The Use of Plasma Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT) and Atrial Natriuretic Peptide (ANP) as Biochemical Markers of Cardiac Injury Associated with Doxorubicin Chemotherapy: A Pilot Study. 21st Annual Conference. Veterinary Cancer Society, Baton Rouge, Louisiana 2001
Canine vascular endothelial growth factor (VEGF) in the effusions of patients with malignant and nonmalignant diseases. 20th Annual Conference. Veterinary Cancer Society, Pacific Grove, California 200,